aluates Reports

$ 0.0

Automative

Global RNA Therapeutics Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-10M15664

Global RNA Therapeutics Market Research Report 2023

BUY CHAPTERS

Global RNA Therapeutics Market Research Report 2025

Code: QYRE-Auto-10M15664

Report

May 2025

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Moderna, Inc

Alnylam Pharmaceuticals

Novartis

Ionis Pharmaceuticals

Sarepta Therapeutics

Sanofi

Arrowhead Pharmaceuticals

Orna Therapeutics

CRISPR Therapeutics

Silence Therapeutics

Astellas Pharma Inc

CureVac

Sirnaomics

Arcturus Therapeutics

Arbutus Biopharma

Pfizer Inc

BioNTech

RNA Therapeutics Market

The global market for RNA Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

RNA therapeutics, also known as RNA-based therapeutics or RNA medicines, refer to a class of medical treatments that utilize RNA molecules to intervene in gene expression and regulation within cells. RNA (ribonucleic acid) is a vital molecule in cells responsible for various biological processes, including protein synthesis and gene regulation.

North American market for RNA Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for RNA Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for RNA Therapeutics in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of RNA Therapeutics include Moderna, Alnylam Pharmaceuticals, Novartis, Ionis Pharmaceuticals, Sarepta Therapeutics, Sanofi, Pfizer, Arrowhead Pharmaceuticals, BioNTech, Orna Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for RNA Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Therapeutics.

The RNA Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global RNA Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the RNA Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of RNA Therapeutics Market Report

Report Metric	Details
Report Name	RNA Therapeutics Market
Segment by Type	mRNA RNA Interference (RNAi) Antisense Oligonucleotide (ASO) Other
Segment by Application	Hospitals Research Institutions
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Moderna, Alnylam Pharmaceuticals, Novartis, Ionis Pharmaceuticals, Sarepta Therapeutics, Sanofi, Pfizer, Arrowhead Pharmaceuticals, BioNTech, Orna Therapeutics, CRISPR Therapeutics, Silence Therapeutics, Astellas Pharma Inc., CureVac, Sirnaomics, Arcturus Therapeutics, Arbutus Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the RNA Therapeutics Market report?

Ans: The main players in the RNA Therapeutics Market are Moderna, Alnylam Pharmaceuticals, Novartis, Ionis Pharmaceuticals, Sarepta Therapeutics, Sanofi, Pfizer, Arrowhead Pharmaceuticals, BioNTech, Orna Therapeutics, CRISPR Therapeutics, Silence Therapeutics, Astellas Pharma Inc., CureVac, Sirnaomics, Arcturus Therapeutics, Arbutus Biopharma

What are the Application segmentation covered in the RNA Therapeutics Market report?

Ans: The Applications covered in the RNA Therapeutics Market report are Hospitals, Research Institutions

What are the Type segmentation covered in the RNA Therapeutics Market report?

Ans: The Types covered in the RNA Therapeutics Market report are mRNA, RNA Interference (RNAi), Antisense Oligonucleotide (ASO), Other

Recommended Reports

RNA & mRNA Therapeutics

Cell & Gene Therapy

Antiviral & Disease Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global RNA Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 mRNA

1.2.3 RNA Interference (RNAi)

1.2.4 Antisense Oligonucleotide (ASO)

1.2.5 Other

1.3 Market by Application

1.3.1 Global RNA Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Research Institutions

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global RNA Therapeutics Market Perspective (2020-2031)

2.2 Global RNA Therapeutics Growth Trends by Region

2.2.1 Global RNA Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 RNA Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 RNA Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 RNA Therapeutics Market Dynamics

2.3.1 RNA Therapeutics Industry Trends

2.3.2 RNA Therapeutics Market Drivers

2.3.3 RNA Therapeutics Market Challenges

2.3.4 RNA Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top RNA Therapeutics Players by Revenue

3.1.1 Global Top RNA Therapeutics Players by Revenue (2020-2025)

3.1.2 Global RNA Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global RNA Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by RNA Therapeutics Revenue

3.4 Global RNA Therapeutics Market Concentration Ratio

3.4.1 Global RNA Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by RNA Therapeutics Revenue in 2024

3.5 Global Key Players of RNA Therapeutics Head office and Area Served

3.6 Global Key Players of RNA Therapeutics, Product and Application

3.7 Global Key Players of RNA Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 RNA Therapeutics Breakdown Data by Type

4.1 Global RNA Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global RNA Therapeutics Forecasted Market Size by Type (2026-2031)

5 RNA Therapeutics Breakdown Data by Application

5.1 Global RNA Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global RNA Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America RNA Therapeutics Market Size (2020-2031)

6.2 North America RNA Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America RNA Therapeutics Market Size by Country (2020-2025)

6.4 North America RNA Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe RNA Therapeutics Market Size (2020-2031)

7.2 Europe RNA Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe RNA Therapeutics Market Size by Country (2020-2025)

7.4 Europe RNA Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific RNA Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific RNA Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific RNA Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific RNA Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America RNA Therapeutics Market Size (2020-2031)

9.2 Latin America RNA Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America RNA Therapeutics Market Size by Country (2020-2025)

9.4 Latin America RNA Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa RNA Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa RNA Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa RNA Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa RNA Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Moderna

11.1.1 Moderna Company Details

11.1.2 Moderna Business Overview

11.1.3 Moderna RNA Therapeutics Introduction

11.1.4 Moderna Revenue in RNA Therapeutics Business (2020-2025)

11.1.5 Moderna Recent Development

11.2 Alnylam Pharmaceuticals

11.2.1 Alnylam Pharmaceuticals Company Details

11.2.2 Alnylam Pharmaceuticals Business Overview

11.2.3 Alnylam Pharmaceuticals RNA Therapeutics Introduction

11.2.4 Alnylam Pharmaceuticals Revenue in RNA Therapeutics Business (2020-2025)

11.2.5 Alnylam Pharmaceuticals Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis RNA Therapeutics Introduction

11.3.4 Novartis Revenue in RNA Therapeutics Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Ionis Pharmaceuticals

11.4.1 Ionis Pharmaceuticals Company Details

11.4.2 Ionis Pharmaceuticals Business Overview

11.4.3 Ionis Pharmaceuticals RNA Therapeutics Introduction

11.4.4 Ionis Pharmaceuticals Revenue in RNA Therapeutics Business (2020-2025)

11.4.5 Ionis Pharmaceuticals Recent Development

11.5 Sarepta Therapeutics

11.5.1 Sarepta Therapeutics Company Details

11.5.2 Sarepta Therapeutics Business Overview

11.5.3 Sarepta Therapeutics RNA Therapeutics Introduction

11.5.4 Sarepta Therapeutics Revenue in RNA Therapeutics Business (2020-2025)

11.5.5 Sarepta Therapeutics Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi RNA Therapeutics Introduction

11.6.4 Sanofi Revenue in RNA Therapeutics Business (2020-2025)

11.6.5 Sanofi Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer RNA Therapeutics Introduction

11.7.4 Pfizer Revenue in RNA Therapeutics Business (2020-2025)

11.7.5 Pfizer Recent Development

11.8 Arrowhead Pharmaceuticals

11.8.1 Arrowhead Pharmaceuticals Company Details

11.8.2 Arrowhead Pharmaceuticals Business Overview

11.8.3 Arrowhead Pharmaceuticals RNA Therapeutics Introduction

11.8.4 Arrowhead Pharmaceuticals Revenue in RNA Therapeutics Business (2020-2025)

11.8.5 Arrowhead Pharmaceuticals Recent Development

11.9 BioNTech

11.9.1 BioNTech Company Details

11.9.2 BioNTech Business Overview

11.9.3 BioNTech RNA Therapeutics Introduction

11.9.4 BioNTech Revenue in RNA Therapeutics Business (2020-2025)

11.9.5 BioNTech Recent Development

11.10 Orna Therapeutics

11.10.1 Orna Therapeutics Company Details

11.10.2 Orna Therapeutics Business Overview

11.10.3 Orna Therapeutics RNA Therapeutics Introduction

11.10.4 Orna Therapeutics Revenue in RNA Therapeutics Business (2020-2025)

11.10.5 Orna Therapeutics Recent Development

11.11 CRISPR Therapeutics

11.11.1 CRISPR Therapeutics Company Details

11.11.2 CRISPR Therapeutics Business Overview

11.11.3 CRISPR Therapeutics RNA Therapeutics Introduction

11.11.4 CRISPR Therapeutics Revenue in RNA Therapeutics Business (2020-2025)

11.11.5 CRISPR Therapeutics Recent Development

11.12 Silence Therapeutics

11.12.1 Silence Therapeutics Company Details

11.12.2 Silence Therapeutics Business Overview

11.12.3 Silence Therapeutics RNA Therapeutics Introduction

11.12.4 Silence Therapeutics Revenue in RNA Therapeutics Business (2020-2025)

11.12.5 Silence Therapeutics Recent Development

11.13 Astellas Pharma Inc.

11.13.1 Astellas Pharma Inc. Company Details

11.13.2 Astellas Pharma Inc. Business Overview

11.13.3 Astellas Pharma Inc. RNA Therapeutics Introduction

11.13.4 Astellas Pharma Inc. Revenue in RNA Therapeutics Business (2020-2025)

11.13.5 Astellas Pharma Inc. Recent Development

11.14 CureVac

11.14.1 CureVac Company Details

11.14.2 CureVac Business Overview

11.14.3 CureVac RNA Therapeutics Introduction

11.14.4 CureVac Revenue in RNA Therapeutics Business (2020-2025)

11.14.5 CureVac Recent Development

11.15 Sirnaomics

11.15.1 Sirnaomics Company Details

11.15.2 Sirnaomics Business Overview

11.15.3 Sirnaomics RNA Therapeutics Introduction

11.15.4 Sirnaomics Revenue in RNA Therapeutics Business (2020-2025)

11.15.5 Sirnaomics Recent Development

11.16 Arcturus Therapeutics

11.16.1 Arcturus Therapeutics Company Details

11.16.2 Arcturus Therapeutics Business Overview

11.16.3 Arcturus Therapeutics RNA Therapeutics Introduction

11.16.4 Arcturus Therapeutics Revenue in RNA Therapeutics Business (2020-2025)

11.16.5 Arcturus Therapeutics Recent Development

11.17 Arbutus Biopharma

11.17.1 Arbutus Biopharma Company Details

11.17.2 Arbutus Biopharma Business Overview

11.17.3 Arbutus Biopharma RNA Therapeutics Introduction

11.17.4 Arbutus Biopharma Revenue in RNA Therapeutics Business (2020-2025)

11.17.5 Arbutus Biopharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Moderna, Inc

Alnylam Pharmaceuticals

Novartis

Ionis Pharmaceuticals

Sarepta Therapeutics

Sanofi

Arrowhead Pharmaceuticals

Orna Therapeutics

CRISPR Therapeutics

Silence Therapeutics

Astellas Pharma Inc

CureVac

Sirnaomics

Arcturus Therapeutics

Arbutus Biopharma

Pfizer Inc

BioNTech

List of Tables

Table 1. Global RNA Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of mRNA

Table 3. Key Players of RNA Interference (RNAi)

Table 4. Key Players of Antisense Oligonucleotide (ASO)

Table 5. Key Players of Other

Table 6. Global RNA Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global RNA Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global RNA Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global RNA Therapeutics Market Share by Region (2020-2025)

Table 10. Global RNA Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global RNA Therapeutics Market Share by Region (2026-2031)

Table 12. RNA Therapeutics Market Trends

Table 13. RNA Therapeutics Market Drivers

Table 14. RNA Therapeutics Market Challenges

Table 15. RNA Therapeutics Market Restraints

Table 16. Global RNA Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global RNA Therapeutics Market Share by Players (2020-2025)

Table 18. Global Top RNA Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Therapeutics as of 2024)

Table 19. Ranking of Global Top RNA Therapeutics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by RNA Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of RNA Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of RNA Therapeutics, Product and Application

Table 23. Global Key Players of RNA Therapeutics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global RNA Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global RNA Therapeutics Revenue Market Share by Type (2020-2025)

Table 27. Global RNA Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global RNA Therapeutics Revenue Market Share by Type (2026-2031)

Table 29. Global RNA Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global RNA Therapeutics Revenue Market Share by Application (2020-2025)

Table 31. Global RNA Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global RNA Therapeutics Revenue Market Share by Application (2026-2031)

Table 33. North America RNA Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America RNA Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America RNA Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe RNA Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe RNA Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe RNA Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific RNA Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific RNA Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific RNA Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America RNA Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America RNA Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America RNA Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa RNA Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa RNA Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa RNA Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Moderna Company Details

Table 49. Moderna Business Overview

Table 50. Moderna RNA Therapeutics Product

Table 51. Moderna Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 52. Moderna Recent Development

Table 53. Alnylam Pharmaceuticals Company Details

Table 54. Alnylam Pharmaceuticals Business Overview

Table 55. Alnylam Pharmaceuticals RNA Therapeutics Product

Table 56. Alnylam Pharmaceuticals Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 57. Alnylam Pharmaceuticals Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis RNA Therapeutics Product

Table 61. Novartis Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. Ionis Pharmaceuticals Company Details

Table 64. Ionis Pharmaceuticals Business Overview

Table 65. Ionis Pharmaceuticals RNA Therapeutics Product

Table 66. Ionis Pharmaceuticals Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 67. Ionis Pharmaceuticals Recent Development

Table 68. Sarepta Therapeutics Company Details

Table 69. Sarepta Therapeutics Business Overview

Table 70. Sarepta Therapeutics RNA Therapeutics Product

Table 71. Sarepta Therapeutics Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 72. Sarepta Therapeutics Recent Development

Table 73. Sanofi Company Details

Table 74. Sanofi Business Overview

Table 75. Sanofi RNA Therapeutics Product

Table 76. Sanofi Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 77. Sanofi Recent Development

Table 78. Pfizer Company Details

Table 79. Pfizer Business Overview

Table 80. Pfizer RNA Therapeutics Product

Table 81. Pfizer Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 82. Pfizer Recent Development

Table 83. Arrowhead Pharmaceuticals Company Details

Table 84. Arrowhead Pharmaceuticals Business Overview

Table 85. Arrowhead Pharmaceuticals RNA Therapeutics Product

Table 86. Arrowhead Pharmaceuticals Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 87. Arrowhead Pharmaceuticals Recent Development

Table 88. BioNTech Company Details

Table 89. BioNTech Business Overview

Table 90. BioNTech RNA Therapeutics Product

Table 91. BioNTech Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 92. BioNTech Recent Development

Table 93. Orna Therapeutics Company Details

Table 94. Orna Therapeutics Business Overview

Table 95. Orna Therapeutics RNA Therapeutics Product

Table 96. Orna Therapeutics Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 97. Orna Therapeutics Recent Development

Table 98. CRISPR Therapeutics Company Details

Table 99. CRISPR Therapeutics Business Overview

Table 100. CRISPR Therapeutics RNA Therapeutics Product

Table 101. CRISPR Therapeutics Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 102. CRISPR Therapeutics Recent Development

Table 103. Silence Therapeutics Company Details

Table 104. Silence Therapeutics Business Overview

Table 105. Silence Therapeutics RNA Therapeutics Product

Table 106. Silence Therapeutics Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 107. Silence Therapeutics Recent Development

Table 108. Astellas Pharma Inc. Company Details

Table 109. Astellas Pharma Inc. Business Overview

Table 110. Astellas Pharma Inc. RNA Therapeutics Product

Table 111. Astellas Pharma Inc. Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 112. Astellas Pharma Inc. Recent Development

Table 113. CureVac Company Details

Table 114. CureVac Business Overview

Table 115. CureVac RNA Therapeutics Product

Table 116. CureVac Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 117. CureVac Recent Development

Table 118. Sirnaomics Company Details

Table 119. Sirnaomics Business Overview

Table 120. Sirnaomics RNA Therapeutics Product

Table 121. Sirnaomics Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 122. Sirnaomics Recent Development

Table 123. Arcturus Therapeutics Company Details

Table 124. Arcturus Therapeutics Business Overview

Table 125. Arcturus Therapeutics RNA Therapeutics Product

Table 126. Arcturus Therapeutics Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 127. Arcturus Therapeutics Recent Development

Table 128. Arbutus Biopharma Company Details

Table 129. Arbutus Biopharma Business Overview

Table 130. Arbutus Biopharma RNA Therapeutics Product

Table 131. Arbutus Biopharma Revenue in RNA Therapeutics Business (2020-2025) & (US$ Million)

Table 132. Arbutus Biopharma Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. RNA Therapeutics Picture

Figure 2. Global RNA Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global RNA Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. mRNA Features

Figure 5. RNA Interference (RNAi) Features

Figure 6. Antisense Oligonucleotide (ASO) Features

Figure 7. Other Features

Figure 8. Global RNA Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global RNA Therapeutics Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Research Institutions Case Studies

Figure 12. RNA Therapeutics Report Years Considered

Figure 13. Global RNA Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global RNA Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global RNA Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global RNA Therapeutics Market Share by Players in 2024

Figure 17. Global Top RNA Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Therapeutics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by RNA Therapeutics Revenue in 2024

Figure 19. North America RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America RNA Therapeutics Market Share by Country (2020-2031)

Figure 21. United States RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe RNA Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific RNA Therapeutics Market Share by Region (2020-2031)

Figure 33. China RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America RNA Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa RNA Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE RNA Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Moderna Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 51. Ionis Pharmaceuticals Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 52. Sarepta Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 54. Pfizer Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 55. Arrowhead Pharmaceuticals Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 56. BioNTech Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 57. Orna Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 58. CRISPR Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 59. Silence Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 60. Astellas Pharma Inc. Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 61. CureVac Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 62. Sirnaomics Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 63. Arcturus Therapeutics Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 64. Arbutus Biopharma Revenue Growth Rate in RNA Therapeutics Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nucleic Acid based Therapy Market Research Report 2024

Global Nucleic acid based Therapeutics Drug Market Research Report 2024

Global Nucleic Acid Therapeutic Market Research Report 2024

Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024

Global Nucleic Acid Drugs Market Research Report 2025

Global RNAi Therapeutics Market Research Report 2024

Global Small Interfering RNA siRNA Drugs Market Research Report 2024

Global RNA Interference RNAi Based Therapeutics Market Research Report 2024

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nucleic Acid Medicine Market Research Report 2025

Global Nucleotide based Therapeutics Market Research Report 2024

Global Circular RNA Drugs Market Research Report 2025

RNAi Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapies for Cancer Treatment Market Research Report 2024

Global Nucleic Acid Based Gene Therapy Market Research Report 2025

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Therapeutics Market Research Report 2024

Global Oligonucleotide based Therapy Medicinal Product Market Research Report 2024

RNA Based Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions